DRKS00020514已完成不适用
Rituximab in pediatric rheumatic diseases: 2 years follow up for immunological long-term effects using a standardized screening and safety protocol.
(Non-profit) Verein: Hilfe für das rheumakranke Kind e.V.0 个研究点目标入组 21 人开始时间: 2020年1月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 18 Years（—）
- 性别
- All
入选标准
- •Severe and/or refractory pediatric rheumatic diseases based on antobody-mediated pathogenesis.
排除标准
- •Acute and severe infection. Primary immunodeficiency.
研究者
相似试验
已完成
不适用
The efficacy of rituximab for children with refractory nephrotic syndromesteroid dependent nephrotic synrdome and frequent relapsing nephrotic syndromeJPRN-UMIN000009411Department of Pediatrics, Kobe University Graduate School of Medicine20
进行中（未招募）
1 期
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM)and Adult Polmyositis (PM) - Rituximab in myositis (RIM)Adult polymyositis or adult dermatomyositis or juvenile dermatomyositis.MedDRA version: 9.1Level: LLTClassification code 10036102Term: PolymyositisEUCTR2006-000078-65-CZKarolinska University Hospital202
进行中（未招募）
1 期
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) - Rituximab in myositisAdult polymyositis or adult dermatomyositis or juvenile dermatomyositisMedDRA version: 8.1Level: LLTClassification code 10036102Term: PolymyositisEUCTR2006-000078-65-GBKarolinska University Hospital202
进行中（未招募）
不适用
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) - Rituximab in myositisAdult polymyositis or adult dermatomyositis or juvenile dermatomyositisMedDRA version: 8.1Level: LLTClassification code 10036102Term: PolymyositisEUCTR2006-000078-65-SEKarolinska University Hospital202
进行中（未招募）
不适用
Re-Treatment with Rituximab in patients with rheumatoid arthritis who have had an inadequate response to not more than one aTNF (extension study to ML19070) - Efficacy of re-therapy in anti-TNFalpha IRMedDRA version: 9.1Level: PTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2006-006746-33-DERoche Pharma AG240